NCHS - U.S. National Center for Health Statistics

06/04/2026 | Press release | Distributed by Public on 06/03/2026 22:17

Parkinson Disease Mortality Among Adults Age 65 and Older: United States, 2024

NCHS Data Brief No. 563, June 2026

PDF Version (642 KB)

Ellen A. Kramarow, Ph.D., Loraine A. Escobedo, Ph.D., M.P.H., and Betzaida Tejada-Vera, M.S

Key findings

Data from the National Vital Statistics System

  • In 2024, the age-adjusted Parkinson disease death rate for adults age 65 and older was 72.0 deaths per 100,000 standard population.
  • Parkinson disease death rates increased from 2014 (57.2) through 2021 (76.3), but the rate in 2024 was lower than in 2021.
  • In 2024, Parkinson disease death rates in adults age 65 and older were higher for men than for women in each age group (65-74, 75-84, and 85 and older).
  • Death rates from Parkinson disease were highest among White non-Hispanic adults age 65 and older compared with other race and Hispanic-origin groups.
  • Parkinson disease death rates varied by state of residence, ranging from 47.7 in New York to 102.1 in Utah.
Article Metrics

Introduction

Parkinson disease is a progressive neurodegenerative disease characterized by tremors, muscle stiffness, slowness in movement, and balance problems. Symptoms tend to worsen over time and sometimes include difficulties in cognitive functioning and other nonmotor symptoms (1,2). In 2024, it was the ninth leading cause of death for adults age 65 and older (3). This report presents Parkinson disease mortality for adults age 65 and older by sex, age group, race and Hispanic origin, and state of residence. Trends in Parkinson disease death rates during 2014-2024 are also presented.

Trends

  • The age-adjusted Parkinson disease death rate for adults age 65 and older increased from 2014 (57.2 deaths per 100,000 standard population) through 2021 (76.3). The death rate in 2024 (72.0) was lower than in 2021 (Figure 1, Table 1).
  • Parkinson disease death rates for men were about 2 times higher than death rates for women throughout the period.
Close
Data table for Figure 1
Data table for Figure 1. Age-adjusted death rate for Parkinson disease among adults age 65 and older, by sex: United States, 2014-2024
Year Total1 Men1,2 Women1
Number Deaths per 100,000 standard population Number Deaths per 100,000 standard population Number Deaths per 100,000 standard population
2014 25,482 57.2 15,240 86.5 10,242 37.8
2015 27,269 59.8 16,388 90.2 10,881 39.4
2016 28,929 62.2 17,373 93.2 11,556 41.1
2017 31,177 65.3 18,872 97.9 12,305 43.0
2018 32,988 67.1 19,943 99.9 13,045 44.5
2019 34,435 68.4 21,015 101.9 13,420 44.8
2020 39,316 76.4 23,837 112.5 15,479 51.0
2021 37,568 76.3 22,952 112.3 14,616 50.8
2022 38,931 73.8 23,867 110.4 15,064 48.5
2023 39,238 73.8 24,133 108.6 15,105 49.0
2024 39,935 72.0 24,690 105.6 15,245 47.6

1Significantly increasing trend from 2014 to 2021 (p < 0.05); decreasing but not statistically significant trend from 2021 to 2024. Rates in 2024 were lower than in 2021 (p < 0.05).
2Significantly higher death rates than those for women throughout the period (p < 0.05).
NOTE: Age-adjusted death rates were calculated using the direct method and the 2000 U.S. standard population.
SOURCE: National Center for Health Statistics, National Vital Statistics System, mortality data file.

Age and sex

  • In 2024, Parkinson disease death rates in adults age 65 and older were higher for men than women in each age group (65-74, 75-84, and 85 and older) (Figure 2, Table 2).
  • Parkinson disease death rates increased with age, from 18.5 deaths per 100,000 population for adults ages 65-74 to 97.2 for adults 75-84 to 227.0 for adults 85 and older.
  • Parkinson disease death rates for men increased from 25.8 for ages 65-74 to 141.0 for 75-84 to 343.3 for 85 and older.
  • Parkinson disease death rates for women increased from 12.0 for ages 65-74 to 62.2 for 75-84 to 157.2 for 85 and older.
Close
Data table for Figure 2
Data table for Figure 2. Death rate for Parkinson disease among adults age 65 and older, by sex and age group: United States, 2024
Age group Total Men1 Women
Number Deaths per 100,000 population Number Deaths per 100,000 population Number Deaths per 100,000 population
65-742 6,562 18.5 4,308 25.8 2,254 12.0
75-843 18,764 97.2 12,095 141.0 6,669 62.2
85 and older 14,609 227.0 8,287 343.3 6,322 157.2

1Significantly different from women for all age groups (p < 0.05).
2Significantly different from 75-84 and 85 and older for all groups (p < 0.05).
3Significantly different from 85 and older for all groups (p < 0.05).
SOURCE: National Center for Health Statistics, National Vital Statistics System, mortality data file.

Race and ethnicity and sex

  • Death rates from Parkinson disease were highest among White non-Hispanic (subsequently, White) adults age 65 and older compared with other race and Hispanic-origin groups (Figure 3, Table 3).
  • Among men age 65 and older, Parkinson disease death rates were highest among White men (118.9 per 100,000 standard population) compared with Hispanic (67.7), Asian non-Hispanic (subsequently, Asian) (60.8), Black non-Hispanic (subsequently, Black) (60.7), and American Indian and Alaska Native non-Hispanic (subsequently, American Indian and Alaska Native (41.2) men.
  • Among women age 65 and older, Parkinson disease death rates were highest among White women (54.0) compared with Hispanic (33.8), Asian (31.9), American Indian and Alaska Native (29.7), and Black (24.1) women.
Close
Data table for Figure 3
Data table for Figure 3. Age-adjusted death rate for Parkinson disease among adults age 65 and older, by sex and race and Hispanic origin: United States, 2024
Race and Hispanic origin Total Men1 Women
Number Deaths per 100,000 standard population Number Deaths per 100,000 standard population Number Deaths per 100,000 standard population
White, non-Hispanic 34,056 281.7 21,212 2118.9 12,844 254.0
Hispanic 2,403 347.8 1,402 367.7 1,001 433.8
Asian, non-Hispanic 1,289 543.9 748 660.8 541 431.9
Black, non-Hispanic 1,879 37.7 1,139 660.7 740 24.1
American Indian and Alaska Native, non-Hispanic 119 35.1 64 41.2 55 29.7

1Significantly different from women for all race and Hispanic-origin groups except for American Indian and Alaska Native non-Hispanic (p < 0.05).
2Significantly different from Hispanic, Asian non-Hispanic, Black non-Hispanic, and American Indian and Alaska Native non-Hispanic people (p < 0.05).
3Significantly different from Asian non-Hispanic, Black non-Hispanic, and American Indian and Alaska Native non-Hispanic people (p < 0.05).
4Significantly different from Black non-Hispanic women (p < 0.05).
5Significantly different from Black non-Hispanic and American Indian and Alaska Native non-Hispanic people (p < 0.05).
6Significantly different from American Indian and Alaska Native non-Hispanic men (p < 0.05).
NOTES: Age-adjusted death rates were calculated using the direct method and the 2000 U.S. standard population. Misclassification of race and Hispanic origin on death certificates results in the underestimation of death rates by 3% for Asian non-Hispanic and Hispanic people and by 34% for American Indian and Alaska Native non-Hispanic people. People of Hispanic origin may be of any race. For race categories, only one race was reported on the death certificate.
SOURCE: National Center for Health Statistics, National Vital Statistics System, mortality data file.

State of residence

  • Age-adjusted death rates for Parkinson disease varied by state of residence, from 47.7 deaths per 100,000 standard population in New York to 102.1 in Utah (Figure 4, Table 4).
  • The states with the highest death rates were Utah (102.1), Kansas (90.6), Nebraska (85.7), Maine (85.0), and Oregon (84.2).
  • The lowest death rates for Parkinson disease were in New York (47.7), Alaska (49.5), the District of Columbia (51.5), Wyoming (54.8), and Hawaii (55.0).
Close
Data table for Figure 4
Data table for Figure 4. Age-adjusted death rate for Parkinson disease among adults age 65 and older, by state: United States, 2024
Area Number Deaths per 100,000 standard population
United States 39,935 72.0
Alabama 694 81.3
Alaska 41 49.5
Arizona 950 67.8
Arkansas 399 77.4
California 4,050 67.5
Colorado 639 76.9
Connecticut 503 75.5
Delaware 141 71.5
District of Columbia 45 51.5
Florida 3,306 66.4
Georgia 1,102 72.2
Hawaii 174 55.0
Idaho 242 79.2
Illinois 1,506 72.5
Indiana 842 77.8
Iowa 456 79.6
Kansas 438 90.6
Kentucky 598 82.1
Louisiana 550 77.4
Maine 251 85.0
Maryland 679 67.7
Massachusetts 878 71.9
Michigan 1,280 72.9
Minnesota 757 78.4
Mississippi 362 78.0
Missouri 893 84.1
Montana 152 73.7
Nebraska 272 85.7
Nevada 303 60.6
New Hampshire 189 70.9
New Jersey 945 59.8
New Mexico 266 69.3
New York 1,698 47.7
North Carolina 1,288 74.8
North Dakota 74 55.9
Ohio 1,555 76.9
Oklahoma 489 79.0
Oregon 633 84.2
Pennsylvania 1,721 70.0
Rhode Island 141 70.9
South Carolina 712 76.6
South Dakota 113 73.0
Tennessee 889 79.7
Texas 3,020 80.4
Utah 369 102.1
Vermont 108 82.7
Virginia 1,162 83.5
Washington 947 78.3
West Virginia 275 78.7
Wisconsin 785 76.8
Wyoming 53 54.8

NOTES: Age-adjusted death rates were calculated using the direct method and the 2000 U.S. standard population. Rate is deaths per 100,000 standard population.
SOURCE: National Center for Health Statistics, National Vital Statistics System, mortality data file.

Summary

This report describes Parkinson disease mortality among adults age 65 and older. In 2024, the age-adjusted death rate for Parkinson disease among adults age 65 and older was 72.0 deaths per 100,000 standard population. Overall and for both men and women, death rates increased from 2014 through 2021 and were lower in 2024 than in 2021. Men had higher death rates from Parkinson disease overall and in each age group. White adults had higher death rates from Parkinson disease than Hispanic, Asian, Black, and American Indian and Alaska Native adults. Variation in death rates was seen by state of residence, ranging from 47.7 in New York to 102.1 in Utah.

Data source and methods

Estimates in this report are based on the National Vital Statistics System mortality files, accessed via CDC WONDER (3). Parkinson disease deaths are identified using the International Classification of Diseases, 10th Revision underlying cause-of-death codes G20 (Parkinson disease) and G21 (Secondary parkinsonism) (4). Age-adjusted death rates were calculated using the direct method and the 2000 U.S. standard population (5). Pairwise comparisons of rates were conducted using a z test with an alpha level of 0.05. Terms such as higher than and lower than indicate a statistically significant difference. Trends in death rates were evaluated using the Joinpoint Regression Program (Version 5.0.2) (6). Joinpoint software fitted weighted least-squares regression models to the rates on the log-transformation scale. The permutation tests for model significance (number of joinpoints) were set at an overall alpha level of 0.05 (6,7).

Race and Hispanic origin were categorized based on the 1997 Office of Management and Budget standards for federal statistical and administrative reporting (8). All race categories are single race, meaning that only one race was reported on the death certificate. Data shown for the Hispanic population include people of any race. Misclassification of race and Hispanic origin on death certificates results in the underestimation of death rates by as much as 34% for American Indian and Alaska Native people and 3% for Asian and Hispanic people (9,10).

About the authors

Ellen A. Kramarow and Loraine A. Escobedo are with the National Center for Health Statistics (NCHS), Division of Analysis and Epidemiology, and Betzaida Tejada-Vera is with the NCHS Division of Vital Statistics.

References

  1. National Institute on Aging. Parkinson's disease: Causes, symptoms, and treatments. 2022. Available from: https://www.nia.nih.gov/health/parkinsons-disease/parkinsons-disease-causes-symptoms-and-treatments.
  2. Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: A review. JAMA. 2020 Feb;323(6):548-60. PMID: 32044947. DOI: https://www.dx.doi.org/10.1001/jama.2019.22360.
  3. Centers for Disease Control and Prevention. CDC WONDER. 2018-2024 underlying cause of death by single-race categories. 2026. Available from: https://wonder.cdc.gov/ucd-icd10-expanded.html.
  4. World Health Organization. International statistical classification of diseases and related health problems, 10th revision (ICD-10). 5th ed. 2016.
  5. Anderson RN, Rosenberg HM. Age standardization of death rates: Implementation of the year 2000 standard. Natl Vital Stat Rep. 1998 Oct; 47(3):1-16. PMID: 9796247.
  6. National Cancer Institute. Joinpoint Regression Program (Version 5.0.2) [computer software]. 2023.
  7. Ingram DD, Malec DJ, Makuc DM, Kruszon-Moran D, Gindi RM, Albert M, et al. National Center for Health Statistics guidelines for analysis of trends. Vital Health Stat 2. 2018 Apr;(179):1-71. PMID: 29775435.
  8. Office of Management and Budget. Revisions to the standards for the classification of federal data on race and ethnicity. Fed Regist. 1997 Oct;62(210):58782-90.
  9. Arias E, Heron M, Hakes J. The validity of race and Hispanic-origin reporting on death certificates in the United States: An update. Vital Health Stat 2. 2016 Aug;(172):1-21. PMID: 28436642.
  10. Arias E, Xu JQ, Curtin S, Bastian B, Tejada-Vera B. Mortality profile of the non-Hispanic American Indian or Alaska Native population, 2019. Natl Vital Stat Rep. 2021 Nov;70(12):1-27. PMID: 34842523. DOI: https://dx.doi.org/10.15620/cdc:110370.

Suggested citation

Kramarow EA, Escobedo LA, Tejada-Vera B. Parkinson disease mortality among adults age 65 and older: United States, 2024. NCHS Data Brief. 2026 Jun;(563):1─11. DOI: https://dx.doi.org/10.15620/cdc/252450.

Copyright information

All material appearing in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

National Center for Health Statistics

Carolyn M. Greene, M.D., Acting Director
 Amy M. Branum, Ph.D., Associate Director for Science

Division of Analysis and Epidemiology
 Irma E. Arispe, Ph.D., Director
 Kimberly A. Lochner, Sc.D., Associate Director for Science

Division of Vital Statistics
 Paul D. Sutton, Ph.D., Director
 Andrés A. Berruti, Ph.D., M.A., Associate Director for Science

NCHS - U.S. National Center for Health Statistics published this content on June 04, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 04, 2026 at 04:17 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]